Feasibility of a Wireless Patch System (WPS) to Measure Gastrointestinal Motility and Gastric Emptying
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Jacksonville, Florida: 22-004957
NCT ID: NCT05555407
About this study
The purpose of this study is to objectively measure gastric motility during a standardized test meal, and over the full course of the WPS test, identify patients with delayed gastric emptying as accurately as a scintigraphic gastric emptying scan.
This study will see if a new wireless patch system (WPS) will be able to objectively measure gastric, small intestine and colonic motility in patients with chronic nausea and vomiting and identify patterns that help distinguish common gastric sensorimotor disorders
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Adult men and women, ≥ 18 years of age.
- Referred to the nuclear medicine department for a scintigraphic gastric emptying scan.
Exclusion Criteria:
- Under 18 years of age.
- Have had prior gastric or esophageal surgery.
- Have had surgery to the GI tract within the last 60 days (e.g., appendectomy, cholecystectomy).
- AAre on chronic opioids or other medications known to affect gastric emptying (e.g., GLP-1 agonists, high dose tricyclic agents).
- Have been recently hospitalized for complications of diabetes or have a HgbA1c > 10.
- Have severe psychological distress preventing study participation.
- Unable to read or understand the consent form.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Jacksonville, Fla.
Mayo Clinic principal investigator Brian Lacy, M.D., Ph.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available